Crestline Management’s Denali Therapeutics DNLI Stock Holding History

Crestline Management’s Portfolio DNLI Stock Details DNLI Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$54M	Sell	3,860,732 -300,000	-7%	-$4.2M	86.33%	1
2025 Q1	$56.6M	Sell	4,160,732 -150,000	-3%	-$2.04M	89.45%	1
2024 Q4	$87.9M	Sell	4,310,732 -150,000	-3%	-$3.06M	2.92%	3
2024 Q3	$130M	Sell	4,460,732 -300,000	-6%	-$8.74M	6.75%	2
2024 Q2	$111M	Sell	4,760,732 -450,000	-9%	-$10.4M	8.6%	2
2024 Q1	$107M	Sell	5,210,732 -450,000	-8%	-$9.23M	9.45%	1
2023 Q4	$121M	Sell	5,660,732 -300,000	-5%	-$6.44M	10.35%	1
2023 Q3	$123M	Sell	5,960,732 -150,000	-2%	-$3.09M	14.32%	1
2023 Q2	$180M	Sell	6,110,732 -300,000	-5%	-$8.85M	18.83%	1
2023 Q1	$148M	Sell	6,410,732 -450,000	-7%	-$10.4M	17.54%	1
2022 Q4	$191M	Sell	6,860,732 -300,000	-4%	-$8.34M	27.96%	1
2022 Q3	$220M	Sell	7,160,732 -300,000	-4%	-$9.21M	29.71%	1
2022 Q2	$220M	Hold	7,460,732	–	–	28.65%	1
2022 Q1	$240M	Sell	7,460,732 -244,307	-3%	-$7.86M	28.78%	1
2021 Q4	$344M	Hold	7,705,039	–	–	25.68%	1
2021 Q3	$389M	Sell	7,705,039 -430,442	-5%	-$21.7M	36.56%	1
2021 Q2	$638M	Sell	8,135,481 -1,849,355	-19%	-$145M	55.02%	1
2021 Q1	$570M	Sell	9,984,836 -9,477,664	-49%	-$541M	72.4%	1
2020 Q4	$339M	Buy	19,462,500 +7,260,866	+60%	+$126M	35.95%	1
2020 Q3	$437M	Sell	12,201,634 -1,443,247	-11%	-$51.7M	64.45%	1
2020 Q2	$330M	Sell	13,644,881 -1,922,855	-12%	-$46.5M	60.47%	1
2020 Q1	$273M	Sell	15,567,736 -3,894,764	-20%	-$68.2M	78.45%	1
2019 Q4	$339M	Hold	19,462,500	–	–	43.9%	1
2019 Q3	$298M	Hold	19,462,500	–	–	48.02%	1
2019 Q2	$404M	Hold	19,462,500	–	–	54.41%	1
2019 Q1	$452M	Hold	19,462,500	–	–	98.01%	1
2018 Q4	$402M	Sell	19,462,500 -1,111,799	-5%	-$23M	60.8%	1
2018 Q3	$447M	Hold	20,574,299	–	–	41.41%	1
2018 Q2	$314M	Hold	20,574,299	–	–	32.97%	1
2018 Q1	$405M	Buy	20,574,299 +1	+0%	+$20	50.4%	1
2017 Q4	$322M	Buy	+20,574,298	New	+$322M	32.96%	2